The hepatopulmonary syndrome is characterized by defects in oxygenation due to
pulmonary abnormalities associated with chronic liver disease. Dyspnea and hypoxemia …

Variceal bleeding is the last step in a chain of events initiated by an increase in portal
pressure, followed by the development and progressive dilation of varices until these finally …

To determine the natural history of portopulmonary hypertension (POPH), a retrospective
screening-right heart catheterization-survival analysis of patients was performed. We …

Background & Aims: Hepatopulmonary syndrome (HPS) affects 10%–30% of patients with
cirrhosis and portal hypertension, but the impact on functional status, quality of life, and …

Rationale: Portopulmonary hypertension (PoPH) can be defined as elevation of pulmonary
arterial pressure and pulmonary vascular resistance in the setting of portal hypertension …

A complex balance exists between endogenous procoagulants and the anticoagulant
system in liver disease patients. Hypercoagulable events occur in cirrhosis patients despite …

Already established as a'classic'in the field, Clinical Tests of Respiratory Function presents
an authoritative yet accessible account of this complex area, fusing the basic principles of …

OBJECTIVE. The hepatopulmonary syndrome is defined as a triad of liver disease,
hypoxemia, and intrapulmonary vascular dilation. The reported prevalence of …

Hepatopulmonary syndrome (HPS) results when chronic liver disease or portal hypertension
causes intrapulmonary microvascular dilatation with hypoxemia. In experimental HPS, tumor …

Anesthetic management still varies widely between liver transplant centers with little data to
indicate best practice. Future research should focus on fluid replacement, prevention and …